Our technology gives failed drug molecules a second chance.

Month: January 2019

28.01.2019 Nanoform signs world-leading sparse data AI expert

PRESS RELEASE 28 January 2019 Nanoform signs world-leading sparse data AI expert Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has announced the appointment of Prof Jukka Corander as Head of AI. Prof Corander will be working closely with Nanoform to apply sparse data AI to enhance Nanoform’s proprietary STARMAP™ nanonization™ technology. Prof …

28.01.2019 Nanoform signs world-leading sparse data AI expertRead More »

14.01.2019 Nanoform set to boost world-class nanonization services with appointment of Chief Technology Officer

PRESS RELEASE 14 January 2019 Nanoform set to boost world-class nanonization services with appointment of Chief Technology Officer Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has appointed Dr Niklas Sandler as Chief Technology Officer. The role will combine significant pharmaceutical R&D knowledge with commercial expertise to develop the technological resources required for …

14.01.2019 Nanoform set to boost world-class nanonization services with appointment of Chief Technology OfficerRead More »

07.01.2019 Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointment

PRESS RELEASE 7 January 2019 Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointment Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has appointed Dr Gonçalo Rebelo de Andrade as Chief of Business Operations. The newly created role will significantly strengthen Nanoform’s commercial organisation and continue its rapid growth through international …

07.01.2019 Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointmentRead More »